Survival Impact of Postoperative Primary Area Radiotherapy on De Novo Metastatic Breast Cancer: A Retrospective Study
Technology in Cancer Research & Treatment · 2025
DOI: 10.1177/15330338251341195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2025. Verfasst von Pingchuan Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical Un…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
The role of radiotherapy (RT) in de novo metastatic breast cancer (dnMBC) patients undergoing surgery remains controversial due to limited evidence. This study aimed to evaluate the impact of postoperative radiotherapy on survival outcomes in this population. Materials and methods We retrospectively analyzed 102 dnMBC patients who underwent surgery at a provincial cancer hospital. Patients were grouped based on whether they received postoperative RT. Baseline characteristics were compared using the chi-square test. Kaplan-Meier analysis and Cox proportional hazards models were used to assess the prognostic impact of postoperative radiotherapy on local recurrence-free survival (LRFS), progression-free survival (PFS), and overall survival (OS).
Results
KM survival analysis showed that postoperative RT significantly improved LRFS (HR = 0.3634, 95%CI 0.1552-0.8508, p = .0197) and PFS (HR = 0.4903, 95%CI 0.3061-0.7855, p = .003) but had no significant effect on OS (HR = 0.7337, 95%CI 0.3514-1.508, p = .5395). Multivariate analysis identified postoperative RT as an independent protective factor for LRFS (HR = 0.265, 95%CI 0.088-0.795, p = .018) and PFS (HR = 0.525, 95%CI 0.313-0.882, p = .015). Subgroup analysis showed that for LRFS, RT had no significant interaction with different subgroup classification variables (all interaction p > .05). However, RT had a significant interaction with N stage for PFS ( p = .016), specifically in N1-3 patients (HR = 0.384, 95% CI 0.221-0.668).
Conclusion
RT may improve disease control in selected dnMBC patients undergoing surgery, particularly those with lymph node metastasis. However, these findings still require further validation in larger, multicenter cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Key Laboratory of Breast Cancer Diagnosis and Treatment Research of Guangxi Department of Education, Guangxi Medical University Cancer Hospital, Nanning, China.
- Guangxi Medical University, Nanning, China.
ORCID-Profile: Pingchuan Li, Lineng Wei, Huawei Yang
Förderung
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
- National Natural Science Foundation of China
Zitieren
APA
Li, P., Wei, L., Ji, Y., & Yang, H. (2025). Survival Impact of Postoperative Primary Area Radiotherapy on De Novo Metastatic Breast Cancer: A Retrospective Study. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338251341195
Vancouver
Li P, Wei L, Ji Y, Yang H. Survival Impact of Postoperative Primary Area Radiotherapy on De Novo Metastatic Breast Cancer: A Retrospective Study. Technology in Cancer Research & Treatment. 2025. doi:10.1177/15330338251341195
BibTeX
@article{Li2025,
author = {Li, Pingchuan and Wei, Lineng and Ji, Yinan and Yang, Huawei},
title = {Survival Impact of Postoperative Primary Area Radiotherapy on De Novo Metastatic Breast Cancer: A Retrospective Study},
journal = {Technology in Cancer Research & Treatment},
year = {2025},
doi = {10.1177/15330338251341195}
}
EUVIMED